BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 19779615)

  • 1. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
    PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
    Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
    J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
    Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
    J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
    Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal influenza immunization with vaccine-coated microneedle arrays.
    Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
    PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
    Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved influenza vaccination in the skin using vaccine coated microneedles.
    Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    Vaccine; 2009 Nov; 27(49):6932-8. PubMed ID: 19761836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
    Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch.
    Zhu W; Li S; Wang C; Yu G; Prausnitz MR; Wang BZ
    Front Immunol; 2018; 9():1705. PubMed ID: 30105019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
    Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of influenza vaccine coated onto microneedles.
    Choi HJ; Yoo DG; Bondy BJ; Quan FS; Compans RW; Kang SM; Prausnitz MR
    Biomaterials; 2012 May; 33(14):3756-69. PubMed ID: 22361098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccination in the skin using microneedles improves protection against influenza.
    Song JM; Kim YC; O E; Compans RW; Prausnitz MR; Kang SM
    Mol Ther; 2012 Jul; 20(7):1472-80. PubMed ID: 22508490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
    Ameri M; Ao Y; Lewis H
    AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
    Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
    J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolving polymer microneedle patches for influenza vaccination.
    Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
    Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.